Eton's Galzin TM And False Ad Suit Survives Dismissal Bid

By Ivan Moreno · August 26, 2026, 8:31 PM EDT

Eton Pharmaceuticals can proceed with trademark infringement and false advertising claims accusing Extreme V of marketing a dietary supplement as a Wilson disease treatment, with a Michigan federal judge finding that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Eton Pharmaceuticals, Inc. v. Extreme V, Inc. et al

Case Number

2:25-cv-12561

Court

Michigan Eastern

Nature of Suit

Trademark

Date Filed

August 15, 2025